Monday, August 30, 2010 7:31:20 AM
1) First, SPPH's technology allows for less painful drug administration, and significantly increases the time over which drugs cab be absorbed into the body, offering more effective treatment.
2) Second, SPPH's technology for drug delivery can be applied to all kinds of prescription drugs out there, and with the drug delivery industry forecasted to reach $80.2 billion in the US by 2012 (as per the The Freedonia Group) the potential market for SPPH's products is ENORMOUS!
The application possibilities for SPPH's drug delivery technology are nearly endless, and that?s why we are so excited about the story. Even with the recent 50% run, we think there could still be significant upside left in the stock, especially if a major decided to wise up and take out the competition!
FEATURED Music Licensing, Inc. (OTC: SONG) Subsidiary Pro Music Rights Secures Final Judgment of $114,081.30 USD, Demonstrating Strength of Licensing Agreements • May 17, 2024 11:00 AM
VPR Brands (VPRB) Reports First Quarter 2024 Financial Results • VPRB • May 17, 2024 8:04 AM
ILUS Provides a First Quarter Filing Update • ILUS • May 16, 2024 11:26 AM
Cannabix Technologies and Omega Laboratories Inc. enter Strategic Partnership to Commercialize Marijuana Breathalyzer Technology • BLO • May 16, 2024 8:13 AM
Avant Technologies to Revolutionize Data Center Management with Proprietary AI Software Platform • AVAI • May 16, 2024 8:00 AM
HealthLynked Corp Announces First Quarter 2024 Results: Achieves 8% Revenue Growth Over Last Quarter • HLYK • May 16, 2024 8:00 AM